Also known as: 1,3-Propanedione, 1-[4-(1,1-dimethylethyl)phenyl]-3-(4-methoxyphenyl)-, 1-(4-(1,1-Dimethylethyl)phenyl)-3-(4-methoxyphenyl)-1,3-propanedione, EINECS 274-581-6, Avobenzona, Avobenzonum (+2 more)
INCI: BUTYL METHOXYDIBENZOYLMETHANE
Avobenzone (CAS 70356-09-1) is a cosmetic active ingredient functioning as Oil-soluble UVA1 UV filter; primary UVA absorber in US-market sunscreens; peak. NOAEL 33.3333 mg/kg bw/day (cross-referenced against ToxValDB ECHA IUCLID); EU Regulation 1223/2009 status: permitted, max 5%. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety and pharmaceutical data.
US NotesFDA OTC monograph active ingredient. Max concentration 3% in US. Classified NOT GRAS per September 27, 2021 proposed administrative order (86 FR 53546) due to systemic absorption exceeding 0.5 ng/mL threshold. FDA stated this does NOT mean the ingredient is unsafe — products remain on market and recommended for continued use. Additional nonclinical toxicology data (carcinogenicity, reproductive) required by FDA.
For full compliance data across multiple jurisdictions, use the
Substance Compliance tool.
Safety Data
Margin of Safety, dermal absorption, and sensitization profile summaries for Avobenzone.
Calculate MoS for your specific formulation with the
MoS Calculator.
Toxicological Studies
3 study endpoints found for Avobenzone. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
Endpoint
Value
Route
Species
Study Type
Source
NOAEL
=360 mg/kg bw/day
dermal
Rabbit
acute
ToxValDB_ECHA_IUCLID
NOAEL
=450 mg/kg bw/day
oral
Rat
chronic
ToxValDB_ECHA_IUCLID
NOAEL
=1000 mg/kg bw/day
oral
Rat
developmental
ToxValDB_ECHA_IUCLID
Pre-Calculated Safety Assessment
Pre-calculated NOAEL → SED → MoS audit trail for Avobenzone across SCCS product categories, with measured dermal absorption where available.
EPA ToxValDB — Toxicity Values
8 toxicity values from EPA ToxValDB (aggregated from CCTE, HPV, ToxRefDB, IRIS, and other regulatory dossiers).
Endpoint
Value
Species
Route
Duration
Source
LD50
>1000 mg/kg
Rat
dermal
acute
ECHA IUCLID
LD50
>16000 mg/kg
Rat
oral
-
ECHA IUCLID
LOAEL
>360 mg/kg-day
Rabbit
dermal
acute
ECHA IUCLID
LOAEL
=100 mg/kg-day
Rabbit
dermal
acute
ECHA IUCLID
LOAEL
=1000 mg/kg-day
Rat
oral
chronic
ECHA IUCLID
NOAEL
=1000 mg/kg-day
Rat
oral
-
ECHA IUCLID
NOAEL
=360 mg/kg-day
Rabbit
dermal
acute
ECHA IUCLID
NOAEL
=450 mg/kg-day
Rat
oral
chronic
ECHA IUCLID
Sensitization AOP Dashboard
Adverse Outcome Pathway data across 5 assays (DPRA, KeratinoSens, hCLAT, LLNA, NESIL) aggregated from public sources.
DPRA Cys %
0%
DPRA Lys %
0%
KeratinoSens IC50
119.712 µM
hCLAT CV75
250 µg/mL
GHS: inconclusive
Source: DPRA: Cosmetics Europe; KS: Cosmetics Europe; hCLAT: Cosmetics Europe
HRIPT Human Patch Test Studies
1 human repeat insult patch test aggregated from dermatological literature.
Test Type
N
Sensitized
Dose µg/cm²
NESIL µg/cm²
Potency
HRIPT
38950
0
-
-
non-sensitizer
Endocrine Disruptor Evidence (Expanded)
Cross-referenced EDC classifications, mechanism data, and dose-response evidence from EDLists, SIN List, and cosmetic-specific detail sources.
SuspectedEvidence: Moderate(2015)
Health effects:Yes
Affected pathways:Estrogenic/Thyroid
Regulatory framework:REACH
Source list: II
Cosmetic-Specific Mechanism
Category:UV filter
Receptor targets:none confirmed in vitro
LOEC:N/A
EU status:allowed (max 5%)
no ER/AR binding detected
Dose-Response Data Points
Endpoint
Target
Value
Direction
Cell proliferation
ER
EC50/IC50: N/A (no significant proliferation observed); LOEC: N/A; NOEC: >=3 uM mixed
inactive
ERb luciferase transcription
ERb
EC50/IC50: ~10-100 uM (EC50 not formally reported); LOEC: 10 uM; NOEC: 1 uM mixed
partial agonist (~60% E2 max)
ECHA REACH Registration
European Chemicals Agency REACH dossier and Substances of Very High Concern listing.
Registration Type
Full
Tonnage Band
1,000 - 10,000 tonnes
Substance Type
SUBSTANCE
SVHC Candidate
No
EU CosIng Annex Listing
European Commission CosIng database Annex references per Regulation (EC) No 1223/2009.
Annex VI — Permitted UV Filters
Max: 5%
Expanded Jurisdictional Detail
Additional regulatory detail beyond the 7-jurisdiction summary: Saudi SFDA, Korea MFDS, ASEAN ACD, Japan/Korea, Brazil/India, and cross-jurisdictional restriction entries.
KR Korea MFDS Annex 2 (Restricted)
Category: UV Filter. Max: 5%.
SA Saudi SFDA (VI - UV Filters)
Max: 0.05.
JPKR Japan/Korea Cosmetics
Japan (Positive (UV Absorber)): max 10.0
Korea (Restricted): max 5.0
Japan (Restricted): max 10%
BRIN Brazil/India Cosmetics
India: Permitted UV Filter · max 0.05
Additional Jurisdictional Restrictions (5)
Jurisdiction
Status
Max %
Product Type
CN
permitted_uv_filter
5
All cosmetics
IN
permitted_uv_filter
5.0
sunscreen and other cosmetic products
GCC
restricted
5.0
Sunscreen products
BR
permitted_uv_filter
5
Sunscreen products
ASEAN
permitted_uv_filter
5%
-
Expanded Dermal Absorption Data
Cross-database dermal penetration: EPA Dryad physics-based, Roberts Mendeley permeation, and SCCS-aggregated measured values.
Aggregated DA Values (2 records across 5 sources)
Type
DA %
Method
Skin Model
SCCS Ref
measured_in_vitro
0.59
In vivo — clinical (plasma monitoring)
-
SCC/EC 2000; CIR review 2025 (2000)
measured_in_vitro
11.5
-
-
SCCS/1617/20
Typical Use Concentrations
Reported concentration ranges per product category from SCCS/CIR/industry sources.
Product Category
Typical Range
Max Reported
Source
Sunscreen
1–3
5
CIR/VCRP
Additional Ingredient Properties
1 property record from structured ingredient metadata.
Avobenzone has a safety rating of "GOOD" in our database. EU status: permitted. US status: restricted. 3 toxicological study endpoint(s) are available in our database.
Is Avobenzone allowed in the EU?
Avobenzone EU regulatory status: permitted. Maximum allowed concentration: 5%. This is based on EU Regulation 1223/2009 and its amendments.
What does Avobenzone do in cosmetics?
Avobenzone functions as: Oil-soluble UVA1 UV filter; primary UVA absorber in US-market sunscreens; peak absorption ~357 nm; photounstable — undergoes keto-enol tautomerization and Norrish type I/II photocleavage upon UV absorption; requires co-formulation with a photostabilizer for sustained UVA protection. It is classified as a Active Ingredient in our database. CAS number: 70356-09-1.
What is the NOAEL for Avobenzone?
The NOAEL (No Observed Adverse Effect Level) for Avobenzone is =360 mg/kg bw/day based on a acute study via dermal route in Rabbit. A total of 3 study endpoints are available. Source: ToxValDB_ECHA_IUCLID.
Is Avobenzone used outside cosmetics?
Avobenzone also appears in industrial chemical safety and pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Compliance Tools
Check Avobenzone compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.